Global Hallux Rigidus Market

Hallux Rigidus Comprehensive Study by Treatment (-Non-Surgical Treatment, Shoe Modification, Orthotic Devices, Medications, Injection Therapy, Physical Therapy, -Surgical Treatment, Bone Spur Removal (Cheilectomy), Joint Fusion (Arthrodesis), Joint Resurfacing (Interpositional Arthroplasty), Joint Replacement), Diagnosis (X-ray, CT-Scan, MRI), End User (Hospitals & Surgical Centres, Home Cares, Orthopaedic Speciality Clinics, Others) Players and Region - Global Market Outlook to 2030

Hallux Rigidus Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 7.5%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Hallux Rigidus
Hallux Rigidus means stiff big toe occurs when the joint at the base of the big toe stiffens. It is the most common arthritic condition in the foot and can make walking painful and difficult. Hallux Rigidus usually develops in adult between the ages of 30 to 60. Hallux Rigidus can be caused by either a traumatic injury or through overuse of foot. Overpronation or too much stress on the joint is one of the reason. Repetitive weight bearing in a dorsiflexed position such as when walking up mountains or driving forward in a rugby scrum or similar conditions can be a factor.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR7.5%


Hallux Rigidus is a Fragmented market due to the presence of less players. The players are focusing on strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Hallux Rigidus market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

DePuy Synthes (United States), Stryker (United States), Zimmer Biomet (United States), Smith & Nephew (United Kingdom), Wright Medical Group (United States), Lifesciences Corporation (United States), Advanced Orthopaedic Solutions (United States), Acumed (United States), Bioretec (Finland), Henry Schein (United States) and STEROID S.p.A (Italy) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Integra Lifescience Corporation (United States), Pfizer Inc. (United States) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Hallux Rigidus market by and Region.



On the basis of geography, the market of Hallux Rigidus has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Treatment, the sub-segment i.e. -Non-Surgical Treatment will boost the Hallux Rigidus market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Diagnosis, the sub-segment i.e. X-ray will boost the Hallux Rigidus market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals & Surgical Centres will boost the Hallux Rigidus market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Advancement of regenerative therapies

Market Growth Drivers:
Increasing prevalence of people suffering from toe infection. and Rising genetic disorders.

Challenges:
The limited treatment option in advanced stages.

Restraints:
High cost of implant devices. and Strict Regulatory approval.

Opportunities:
Technological advancement in surgical treatment

Market Leaders and their expansionary development strategies
In February 2022, DePuy Synthes acquired CrossRoads Extremity Systems, sterile packed implants and instrumentation systems cleared for lower extremity indication. This acquisition further demonstrates DePuy Synthes Commitment to driving orthopaedic, podiatric, and medtech advancement through both internal and external innovation to deliver industry leading technology that improves patient lives.
In September 2023, Stryker announced the launch of PROstep MIS Lapidus, a new internal fixation system intended for treating bunions using a minimally invasive surgical reduction of hallux valgus deformity and subsequent fusion of the first metatarsal cuneiform joint.


Key Target Audience
Research and Development, Regulatory Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Treatment
  • -Non-Surgical Treatment
  • Shoe Modification
  • Orthotic Devices
  • Medications
  • Injection Therapy
  • Physical Therapy
  • -Surgical Treatment
  • Bone Spur Removal (Cheilectomy)
  • Joint Fusion (Arthrodesis)
  • Joint Resurfacing (Interpositional Arthroplasty)
  • Joint Replacement

By Diagnosis
  • X-ray
  • CT-Scan
  • MRI

By End User
  • Hospitals & Surgical Centres
  • Home Cares
  • Orthopaedic Speciality Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing prevalence of people suffering from toe infection.
      • 3.2.2. Rising genetic disorders.
    • 3.3. Market Challenges
      • 3.3.1. The limited treatment option in advanced stages.
    • 3.4. Market Trends
      • 3.4.1. Advancement of regenerative therapies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Hallux Rigidus, by Treatment, Diagnosis, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Hallux Rigidus (Value)
      • 5.2.1. Global Hallux Rigidus by: Treatment (Value)
        • 5.2.1.1. -Non-Surgical Treatment
        • 5.2.1.2. Shoe Modification
        • 5.2.1.3. Orthotic Devices
        • 5.2.1.4. Medications
        • 5.2.1.5. Injection Therapy
        • 5.2.1.6. Physical Therapy
        • 5.2.1.7. -Surgical Treatment
        • 5.2.1.8. Bone Spur Removal (Cheilectomy)
        • 5.2.1.9. Joint Fusion (Arthrodesis)
        • 5.2.1.10. Joint Resurfacing (Interpositional Arthroplasty)
        • 5.2.1.11. Joint Replacement
      • 5.2.2. Global Hallux Rigidus by: Diagnosis (Value)
        • 5.2.2.1. X-ray
        • 5.2.2.2. CT-Scan
        • 5.2.2.3. MRI
      • 5.2.3. Global Hallux Rigidus by: End User (Value)
        • 5.2.3.1. Hospitals & Surgical Centres
        • 5.2.3.2. Home Cares
        • 5.2.3.3. Orthopaedic Speciality Clinics
        • 5.2.3.4. Others
      • 5.2.4. Global Hallux Rigidus Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Hallux Rigidus: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. DePuy Synthes (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Stryker (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Zimmer Biomet (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Smith & Nephew (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Wright Medical Group (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Lifesciences Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Advanced Orthopaedic Solutions (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Acumed (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bioretec (Finland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Henry Schein (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. STEROID S.p.A (Italy)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Hallux Rigidus Sale, by Treatment, Diagnosis, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Hallux Rigidus (Value)
      • 7.2.1. Global Hallux Rigidus by: Treatment (Value)
        • 7.2.1.1. -Non-Surgical Treatment
        • 7.2.1.2. Shoe Modification
        • 7.2.1.3. Orthotic Devices
        • 7.2.1.4. Medications
        • 7.2.1.5. Injection Therapy
        • 7.2.1.6. Physical Therapy
        • 7.2.1.7. -Surgical Treatment
        • 7.2.1.8. Bone Spur Removal (Cheilectomy)
        • 7.2.1.9. Joint Fusion (Arthrodesis)
        • 7.2.1.10. Joint Resurfacing (Interpositional Arthroplasty)
        • 7.2.1.11. Joint Replacement
      • 7.2.2. Global Hallux Rigidus by: Diagnosis (Value)
        • 7.2.2.1. X-ray
        • 7.2.2.2. CT-Scan
        • 7.2.2.3. MRI
      • 7.2.3. Global Hallux Rigidus by: End User (Value)
        • 7.2.3.1. Hospitals & Surgical Centres
        • 7.2.3.2. Home Cares
        • 7.2.3.3. Orthopaedic Speciality Clinics
        • 7.2.3.4. Others
      • 7.2.4. Global Hallux Rigidus Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Hallux Rigidus: by Treatment(USD Million)
  • Table 2. Hallux Rigidus -Non-Surgical Treatment , by Region USD Million (2018-2023)
  • Table 3. Hallux Rigidus Shoe Modification , by Region USD Million (2018-2023)
  • Table 4. Hallux Rigidus Orthotic Devices , by Region USD Million (2018-2023)
  • Table 5. Hallux Rigidus Medications , by Region USD Million (2018-2023)
  • Table 6. Hallux Rigidus Injection Therapy , by Region USD Million (2018-2023)
  • Table 7. Hallux Rigidus Physical Therapy , by Region USD Million (2018-2023)
  • Table 8. Hallux Rigidus -Surgical Treatment , by Region USD Million (2018-2023)
  • Table 9. Hallux Rigidus Bone Spur Removal (Cheilectomy) , by Region USD Million (2018-2023)
  • Table 10. Hallux Rigidus Joint Fusion (Arthrodesis) , by Region USD Million (2018-2023)
  • Table 11. Hallux Rigidus Joint Resurfacing (Interpositional Arthroplasty) , by Region USD Million (2018-2023)
  • Table 12. Hallux Rigidus Joint Replacement , by Region USD Million (2018-2023)
  • Table 13. Hallux Rigidus: by Diagnosis(USD Million)
  • Table 14. Hallux Rigidus X-ray , by Region USD Million (2018-2023)
  • Table 15. Hallux Rigidus CT-Scan , by Region USD Million (2018-2023)
  • Table 16. Hallux Rigidus MRI , by Region USD Million (2018-2023)
  • Table 17. Hallux Rigidus: by End User(USD Million)
  • Table 18. Hallux Rigidus Hospitals & Surgical Centres , by Region USD Million (2018-2023)
  • Table 19. Hallux Rigidus Home Cares , by Region USD Million (2018-2023)
  • Table 20. Hallux Rigidus Orthopaedic Speciality Clinics , by Region USD Million (2018-2023)
  • Table 21. Hallux Rigidus Others , by Region USD Million (2018-2023)
  • Table 22. South America Hallux Rigidus, by Country USD Million (2018-2023)
  • Table 23. South America Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 24. South America Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 25. South America Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 26. Brazil Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 27. Brazil Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 28. Brazil Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 29. Argentina Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 30. Argentina Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 31. Argentina Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 32. Rest of South America Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 33. Rest of South America Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 34. Rest of South America Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 35. Asia Pacific Hallux Rigidus, by Country USD Million (2018-2023)
  • Table 36. Asia Pacific Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 37. Asia Pacific Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 38. Asia Pacific Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 39. China Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 40. China Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 41. China Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 42. Japan Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 43. Japan Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 44. Japan Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 45. India Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 46. India Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 47. India Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 48. South Korea Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 49. South Korea Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 50. South Korea Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 51. Taiwan Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 52. Taiwan Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 53. Taiwan Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 54. Australia Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 55. Australia Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 56. Australia Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 57. Rest of Asia-Pacific Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 58. Rest of Asia-Pacific Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 59. Rest of Asia-Pacific Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 60. Europe Hallux Rigidus, by Country USD Million (2018-2023)
  • Table 61. Europe Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 62. Europe Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 63. Europe Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 64. Germany Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 65. Germany Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 66. Germany Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 67. France Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 68. France Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 69. France Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 70. Italy Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 71. Italy Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 72. Italy Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 73. United Kingdom Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 74. United Kingdom Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 75. United Kingdom Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 76. Netherlands Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 77. Netherlands Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 78. Netherlands Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 79. Rest of Europe Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 80. Rest of Europe Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 81. Rest of Europe Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 82. MEA Hallux Rigidus, by Country USD Million (2018-2023)
  • Table 83. MEA Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 84. MEA Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 85. MEA Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 86. Middle East Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 87. Middle East Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 88. Middle East Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 89. Africa Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 90. Africa Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 91. Africa Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 92. North America Hallux Rigidus, by Country USD Million (2018-2023)
  • Table 93. North America Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 94. North America Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 95. North America Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 96. United States Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 97. United States Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 98. United States Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 99. Canada Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 100. Canada Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 101. Canada Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 102. Mexico Hallux Rigidus, by Treatment USD Million (2018-2023)
  • Table 103. Mexico Hallux Rigidus, by Diagnosis USD Million (2018-2023)
  • Table 104. Mexico Hallux Rigidus, by End User USD Million (2018-2023)
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Company Basic Information, Sales Area and Its Competitors
  • Table 116. Hallux Rigidus: by Treatment(USD Million)
  • Table 117. Hallux Rigidus -Non-Surgical Treatment , by Region USD Million (2025-2030)
  • Table 118. Hallux Rigidus Shoe Modification , by Region USD Million (2025-2030)
  • Table 119. Hallux Rigidus Orthotic Devices , by Region USD Million (2025-2030)
  • Table 120. Hallux Rigidus Medications , by Region USD Million (2025-2030)
  • Table 121. Hallux Rigidus Injection Therapy , by Region USD Million (2025-2030)
  • Table 122. Hallux Rigidus Physical Therapy , by Region USD Million (2025-2030)
  • Table 123. Hallux Rigidus -Surgical Treatment , by Region USD Million (2025-2030)
  • Table 124. Hallux Rigidus Bone Spur Removal (Cheilectomy) , by Region USD Million (2025-2030)
  • Table 125. Hallux Rigidus Joint Fusion (Arthrodesis) , by Region USD Million (2025-2030)
  • Table 126. Hallux Rigidus Joint Resurfacing (Interpositional Arthroplasty) , by Region USD Million (2025-2030)
  • Table 127. Hallux Rigidus Joint Replacement , by Region USD Million (2025-2030)
  • Table 128. Hallux Rigidus: by Diagnosis(USD Million)
  • Table 129. Hallux Rigidus X-ray , by Region USD Million (2025-2030)
  • Table 130. Hallux Rigidus CT-Scan , by Region USD Million (2025-2030)
  • Table 131. Hallux Rigidus MRI , by Region USD Million (2025-2030)
  • Table 132. Hallux Rigidus: by End User(USD Million)
  • Table 133. Hallux Rigidus Hospitals & Surgical Centres , by Region USD Million (2025-2030)
  • Table 134. Hallux Rigidus Home Cares , by Region USD Million (2025-2030)
  • Table 135. Hallux Rigidus Orthopaedic Speciality Clinics , by Region USD Million (2025-2030)
  • Table 136. Hallux Rigidus Others , by Region USD Million (2025-2030)
  • Table 137. South America Hallux Rigidus, by Country USD Million (2025-2030)
  • Table 138. South America Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 139. South America Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 140. South America Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 141. Brazil Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 142. Brazil Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 143. Brazil Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 144. Argentina Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 145. Argentina Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 146. Argentina Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 147. Rest of South America Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 148. Rest of South America Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 149. Rest of South America Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 150. Asia Pacific Hallux Rigidus, by Country USD Million (2025-2030)
  • Table 151. Asia Pacific Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 152. Asia Pacific Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 153. Asia Pacific Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 154. China Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 155. China Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 156. China Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 157. Japan Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 158. Japan Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 159. Japan Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 160. India Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 161. India Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 162. India Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 163. South Korea Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 164. South Korea Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 165. South Korea Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 166. Taiwan Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 167. Taiwan Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 168. Taiwan Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 169. Australia Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 170. Australia Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 171. Australia Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 172. Rest of Asia-Pacific Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 173. Rest of Asia-Pacific Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 174. Rest of Asia-Pacific Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 175. Europe Hallux Rigidus, by Country USD Million (2025-2030)
  • Table 176. Europe Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 177. Europe Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 178. Europe Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 179. Germany Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 180. Germany Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 181. Germany Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 182. France Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 183. France Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 184. France Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 185. Italy Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 186. Italy Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 187. Italy Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 188. United Kingdom Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 189. United Kingdom Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 190. United Kingdom Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 191. Netherlands Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 192. Netherlands Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 193. Netherlands Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 194. Rest of Europe Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 195. Rest of Europe Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 196. Rest of Europe Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 197. MEA Hallux Rigidus, by Country USD Million (2025-2030)
  • Table 198. MEA Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 199. MEA Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 200. MEA Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 201. Middle East Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 202. Middle East Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 203. Middle East Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 204. Africa Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 205. Africa Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 206. Africa Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 207. North America Hallux Rigidus, by Country USD Million (2025-2030)
  • Table 208. North America Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 209. North America Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 210. North America Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 211. United States Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 212. United States Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 213. United States Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 214. Canada Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 215. Canada Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 216. Canada Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 217. Mexico Hallux Rigidus, by Treatment USD Million (2025-2030)
  • Table 218. Mexico Hallux Rigidus, by Diagnosis USD Million (2025-2030)
  • Table 219. Mexico Hallux Rigidus, by End User USD Million (2025-2030)
  • Table 220. Research Programs/Design for This Report
  • Table 221. Key Data Information from Secondary Sources
  • Table 222. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Hallux Rigidus: by Treatment USD Million (2018-2023)
  • Figure 5. Global Hallux Rigidus: by Diagnosis USD Million (2018-2023)
  • Figure 6. Global Hallux Rigidus: by End User USD Million (2018-2023)
  • Figure 7. South America Hallux Rigidus Share (%), by Country
  • Figure 8. Asia Pacific Hallux Rigidus Share (%), by Country
  • Figure 9. Europe Hallux Rigidus Share (%), by Country
  • Figure 10. MEA Hallux Rigidus Share (%), by Country
  • Figure 11. North America Hallux Rigidus Share (%), by Country
  • Figure 12. Global Hallux Rigidus share by Players 2023 (%)
  • Figure 13. Global Hallux Rigidus share by Players (Top 3) 2023(%)
  • Figure 14. Global Hallux Rigidus share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. DePuy Synthes (United States) Revenue, Net Income and Gross profit
  • Figure 17. DePuy Synthes (United States) Revenue: by Geography 2023
  • Figure 18. Stryker (United States) Revenue, Net Income and Gross profit
  • Figure 19. Stryker (United States) Revenue: by Geography 2023
  • Figure 20. Zimmer Biomet (United States) Revenue, Net Income and Gross profit
  • Figure 21. Zimmer Biomet (United States) Revenue: by Geography 2023
  • Figure 22. Smith & Nephew (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 23. Smith & Nephew (United Kingdom) Revenue: by Geography 2023
  • Figure 24. Wright Medical Group (United States) Revenue, Net Income and Gross profit
  • Figure 25. Wright Medical Group (United States) Revenue: by Geography 2023
  • Figure 26. Lifesciences Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. Lifesciences Corporation (United States) Revenue: by Geography 2023
  • Figure 28. Advanced Orthopaedic Solutions (United States) Revenue, Net Income and Gross profit
  • Figure 29. Advanced Orthopaedic Solutions (United States) Revenue: by Geography 2023
  • Figure 30. Acumed (United States) Revenue, Net Income and Gross profit
  • Figure 31. Acumed (United States) Revenue: by Geography 2023
  • Figure 32. Bioretec (Finland) Revenue, Net Income and Gross profit
  • Figure 33. Bioretec (Finland) Revenue: by Geography 2023
  • Figure 34. Henry Schein (United States) Revenue, Net Income and Gross profit
  • Figure 35. Henry Schein (United States) Revenue: by Geography 2023
  • Figure 36. STEROID S.p.A (Italy) Revenue, Net Income and Gross profit
  • Figure 37. STEROID S.p.A (Italy) Revenue: by Geography 2023
  • Figure 38. Global Hallux Rigidus: by Treatment USD Million (2025-2030)
  • Figure 39. Global Hallux Rigidus: by Diagnosis USD Million (2025-2030)
  • Figure 40. Global Hallux Rigidus: by End User USD Million (2025-2030)
  • Figure 41. South America Hallux Rigidus Share (%), by Country
  • Figure 42. Asia Pacific Hallux Rigidus Share (%), by Country
  • Figure 43. Europe Hallux Rigidus Share (%), by Country
  • Figure 44. MEA Hallux Rigidus Share (%), by Country
  • Figure 45. North America Hallux Rigidus Share (%), by Country
List of companies from research coverage that are profiled in the study
  • DePuy Synthes (United States)
  • Stryker (United States)
  • Zimmer Biomet (United States)
  • Smith & Nephew (United Kingdom)
  • Wright Medical Group (United States)
  • Lifesciences Corporation (United States)
  • Advanced Orthopaedic Solutions (United States)
  • Acumed (United States)
  • Bioretec (Finland)
  • Henry Schein (United States)
  • STEROID S.p.A (Italy)
Additional players considered in the study are as follows:
Integra Lifescience Corporation (United States) , Pfizer Inc. (United States) , Others
Select User Access Type

Key Highlights of Report


Feb 2024 206 Pages 94 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Hallux Rigidus Market Quantitative research analysis
Global Hallux Rigidus Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as DePuy Synthes (United States), Stryker (United States), Zimmer Biomet (United States), Smith & Nephew (United Kingdom), Wright Medical Group (United States), Lifesciences Corporation (United States), Advanced Orthopaedic Solutions (United States), Acumed (United States), Bioretec (Finland), Henry Schein (United States) and STEROID S.p.A (Italy) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Advancement of regenerative therapies" is seen as one of major influencing trends for Hallux Rigidus Market during projected period 2023-2030.
The Hallux Rigidus market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.
Analysts at AMA estimates Hallux Rigidus Market to reach USD85700.0 Million by 2030.

Know More About Global Hallux Rigidus Market Report?

Have a Query? Click Here

Other Related Reports

Teledermatology Comprehensive Study by Application (Direct consultations, Specialist referral, Online patient triage, Virtual prescription renewals, Patient follow-up care), Type (Synchronous, Asynch...
$ 3800
Retinal Detachment- Comprehensive Study by Type (Rhegmatogenous, Tractional, Exudative), Treatment Type (Surgical Others, Laser Therapy, Cryopexy, Others), End User (Hospitals, Speciality centre, Cl...
$ 3800
Autism Disorder and Treatment- Comprehensive Study by Therapy (Antipsychotic Drugs, Selective Serotonin Reuptake Inhibitors (SSRI) /Antidepressants, Stimulants, Sleep Medications, Others), Type (Auti...
$ 3800
Bone Pain Treatment- Comprehensive Study by Treatment (Therapies, Surgery, Antibiotics, Others), Indication (Injury, Trauma, Bone Tumour, Infection, Others), End User (Hospital, Speciality Clinics, ...
$ 3800
Hemianopsia- Comprehensive Study by Type (Bitemporal, Homonymous, Heteronymous, Superior, Inferior, Others), Treatment (Vision Restoration Therapy (VRT), Visual Field Expander Aid, Visual Auditory Tr...
$ 3800
Allergic Rhinitis- Comprehensive Study by Type (Perennial Allergic Rhinitis, Seasonal Allergic Rhinitis, Occupational Allergic Rhinitis), Treatment (Immunotherapy, Antihistamines, Decongestant, Corti...
$ 3800